Elisa Romeo

CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity.

Proximal renal tubular acidosis in TASK2 K+ channel-deficient mice reveals a mechanism for stabilizing bicarbonate transport.

Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells.

Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder.

Isolation of a novel KIR2DL3-specific mAb: comparative analysis of the surface distribution and function of KIR2DL2, KIR2DL3 and KIR2DS2.

Heteromeric KCNE2/KCNQ1 potassium channels in the luminal membrane of gastric parietal cells.

Novel renal amino acid transporters.

Luminal kidney and intestine SLC6 amino acid transporters of B0AT-cluster and their tissue distribution in Mus musculus.

Neutral amino acid transport mediated by ortholog of imino acid transporter SIT1/SLC6A20 in opossum kidney cells.

Shunt-associated migraines respond favorably to changes in work conditions.

Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function.

[PM 10 exposure and asthma exacerbations in pediatric age: a meta-analysis of panel and time-series studies].

COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARdelta activation.

Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors.

Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function.

Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity.

Orphan transporter SLC6A18 is renal neutral amino acid transporter B0AT3.

GPR56 as a novel marker identifying the CD56dull CD16+ NK cell subset both in blood stream and in inflamed peripheral tissues.

Short-term effects of PM10 and NO2 on respiratory health among children with asthma or asthma-like symptoms: a systematic review and meta-analysis.

A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2.

Combined genotypic and phenotypic killer cell Ig-like receptor analyses reveal KIR2DL3 alleles displaying unexpected monoclonal antibody reactivity: identification of the amino acid residues critical for staining.

Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT.

Pleural malignant mesothelioma epidemic: incidence, modalities of asbestos exposure and occupations involved from the Italian National Register.

Breast cancer misclassification: a major obstacle to treatment?

A binding site for nonsteroidal anti-inflammatory drugs in fatty acid amide hydrolase.

[Occupational exposure to asbestos and incidence of malignant mesothelioma in the Lazio region, years 2001-2009: results of the activities of the regional register].

Development of fragment-based n-FABS NMR screening applied to the membrane enzyme FAAH.

Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors.

Fluorine NMR-based screening on cell membrane extracts.

Familial malignant mesothelioma: a population-based study in central Italy (1980-2012).

β-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal Cysteine.

A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation.

Epidemiological patterns of asbestos exposure and spatial clusters of incident cases of malignant mesothelioma from the Italian national registry.

Activity-Based Probe for N-Acylethanolamine Acid Amidase.

Fluorine nuclear magnetic resonance-based assay in living mammalian cells.

[Time trend in mesothelioma and lung cancer risk in asbestos workers in Italy].

Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis.

Pathology reporting of malignant pleural mesothelioma first diagnosis: A population-based approach.

Bile Acid Recognition by NAPE-PLD.

Mesothelioma families without inheritance of a BAP1 predisposing mutation.